Monday, 16 November 2026Follow on 𝕏

Policy Page 2

Policy

Navigating Trump’s New Pharmaceutical Tariffs

New tariffs introduced by Donald Trump in April 2026 create significant legal and compliance challenges for pharmaceutical companies. The policy imposes tariffs of up to 100% on patented drugs and related ingredients under Section 232 of…

Policy

Trump secures final drug pricing accord with Regeneron

US President Donald Trump has announced a pricing agreement with Regeneron Pharmaceuticals, marking the final deal in a series of negotiations between the administration and leading drugmakers aimed at lowering the cost of medicines in the…